Description
Trading in equity shares of MODERN DIAGNOSTIC & RESEARCH CENTRE LIMITED (Scrip Code: 544673) will be transferred from Trade for Trade segment (MT Group) to Rolling segment (M Group) effective January 21, 2026.
Summary
BSE has announced that the equity shares of MODERN DIAGNOSTIC & RESEARCH CENTRE LIMITED (Scrip Code: 544673), currently listed on the SME platform, will be transferred from the Trade for Trade segment (MT Group) to the Rolling segment under M Group effective January 21, 2026. This change follows the company’s SME IPO listing and represents a transition to normal rolling settlement.
Key Points
- Company: MODERN DIAGNOSTIC & RESEARCH CENTRE LIMITED (SME IPO)
- Scrip Code: 544673
- Current segment: Trade for Trade segment (MT Group)
- New segment: Rolling segment (M Group)
- Effective date: Wednesday, January 21, 2026
- Reference: Continuation of Notice No. 20260106-16 dated January 06, 2026
- Contact: Mr. Anurag Jain, Tel: 022-2272 8822
Regulatory Changes
The equity shares will transition from Trade for Trade settlement mechanism to Rolling settlement mechanism. This shift from MT Group to M Group allows for regular T+2 settlement cycle instead of mandatory delivery-based trading.
Compliance Requirements
Trading members are required to:
- Note the segment change effective January 21, 2026
- Update their systems to reflect the new group classification (M Group)
- Contact the designated BSE official for any clarifications regarding the transition
Important Dates
- Notice Date: January 7, 2026
- Effective Date: January 21, 2026 (Wednesday)
- Previous Notice: January 6, 2026 (Notice No. 20260106-16)
Impact Assessment
This change is positive for market participants as it:
- Increases liquidity by allowing intraday trading and carry forward positions
- Removes the mandatory delivery requirement of Trade for Trade segment
- Enables normal rolling settlement (T+2) for the scrip
- Reflects the company’s successful transition from initial SME IPO listing to regular trading status
- May attract more trader participation due to relaxed settlement requirements
Impact Justification
Routine transition from Trade for Trade to Rolling segment post-SME IPO listing. Affects trading mechanism and liquidity for the specific scrip but is standard procedure.